Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-11-15 | Wave Life Sciences Ltd. | BOLNO PAUL
(President and CEO) |
S | Ordinary Shares | D | 51234 | $14.32 - $14.32 | $733,670 |
| 2024-11-08 | Wave Life Sciences Ltd. | Francis Chris
(See Remarks) |
S | Ordinary Shares | D | 36000 | $16.00 - $16.00 | $576,000 |
| 2024-11-08 | Wave Life Sciences Ltd. | Francis Chris
(See Remarks) |
M | Ordinary Shares | A | 36000 | $8.17 - $8.17 | $294,120 |
| 2024-10-16 | Wave Life Sciences Ltd. | Francis Chris
(See Remarks) |
S | Ordinary Shares | D | 208836 | $13.00 - $14.00 | $2,855,050 |
| 2024-10-16 | Wave Life Sciences Ltd. | Francis Chris
(See Remarks) |
M | Ordinary Shares | A | 129122 | $2.48 - $3.14 | $371,409 |
| 2024-10-16 | Wave Life Sciences Ltd. | BOLNO PAUL
(President and CEO) |
S | Ordinary Shares | D | 90474 | $15.00 - $15.00 | $1,357,110 |
| 2024-10-11 | Wave Life Sciences Ltd. | Moran Kyle
(Chief Financial Officer) |
M | Ordinary Shares | A | 25000 | $2.48 - $2.48 | $62,000 |
| 2024-09-27 | Wave Life Sciences Ltd. | GSK plc
(AtLeastTenPercentOwner) |
P | Ordinary Shares | A | 2791930 | $8.00 - $8.00 | $22,335,440 |
| 2024-09-25 | Wave Life Sciences Ltd. | Moran Kyle
(Chief Financial Officer) |
S | Ordinary Shares | D | 17146 | $9.00 - $9.00 | $154,314 |
| 2024-08-21 | Wave Life Sciences Ltd. | BOLNO PAUL
(President and CEO) |
S | Ordinary Shares | D | 48366 | $5.78 - $5.78 | $279,555 |
| 2024-08-12 | Wave Life Sciences Ltd. | Shah Rajeev M.
(Director) |
A | Ordinary Shares | A | 16115 | $0.00 - $0.00 | $0 |
| 2024-08-12 | Wave Life Sciences Ltd. | Rawcliffe Adrian
(Director) |
A | Ordinary Shares | A | 16115 | $0.00 - $0.00 | $0 |
| 2024-08-12 | Wave Life Sciences Ltd. | Tan Aik Na
(Director) |
A | Ordinary Shares | A | 16115 | $0.00 - $0.00 | $0 |
| 2024-08-12 | Wave Life Sciences Ltd. | HENRY CHRISTIAN O
(Director) |
A | Ordinary Shares | A | 16115 | $0.00 - $0.00 | $0 |
| 2024-08-12 | Wave Life Sciences Ltd. | CORRIGAN MARK
(Director) |
A | Ordinary Shares | A | 32230 | $0.00 - $0.00 | $0 |
| 2024-08-12 | Wave Life Sciences Ltd. | Verdine Gregory L.
(Director) |
A | Ordinary Shares | A | 16115 | $0.00 - $0.00 | $0 |
| 2024-08-12 | Wave Life Sciences Ltd. | Wagner Heidi L
(Director) |
A | Ordinary Shares | A | 32230 | $0.00 - $0.00 | $0 |
| 2024-08-12 | Wave Life Sciences Ltd. | TAKANASHI KEN
(Director) |
A | Ordinary Shares | A | 16115 | $0.00 - $0.00 | $0 |
| 2024-07-22 | Wave Life Sciences Ltd. | Vargeese Chandra
(See Remarks) |
M | Ordinary Shares | A | 68210 | $2.48 - $2.48 | $169,160 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |